Comorbidity affective disorders and alcohol use disorder;Troubles affectifs et comorbidités éthyliques

Encephale

Volumn 40, Issue S3, 2014, Pages S3-S7

  Pringuey, D ^a   Cherikh, F ^a   Lunacek, S ^a   Giordana, B ^a   Fakra, E ^b   Belzeaux, R ^b   Adida, M ^b   Azorin, J M ^b  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

affective disorders; alcohol use disorder; Comorbidity; Psychiatric; vulnerability factors

Indexed keywords

ALCOHOL; CLOCK PROTEIN, HUMAN; SEROTONIN TRANSPORTER; TRANSCRIPTION FACTOR CLOCK;

ALCOHOL USE DISORDER; ARTICLE; BIPOLAR DISORDER; COMORBIDITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; MENTAL DISEASE; MOOD DISORDER; SUICIDE; TREATMENT RESPONSE; ALCOHOLISM; CROSS-SECTIONAL STUDY; FRANCE; GENETIC PREDISPOSITION; GENETICS; HUMAN; INTERDISCIPLINARY COMMUNICATION; MOOD DISORDERS; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGY; RISK FACTOR;

ALCOHOLISM; BIPOLAR DISORDER; CLOCK PROTEINS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DUAL (PSYCHIATRY); FRANCE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERDISCIPLINARY COMMUNICATION; MOOD DISORDERS; RISK FACTORS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SUICIDE;

EID: 84920515719     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0013-7006(14)70123-X     Document Type: Article

References (30)

1. Casas M. Introduction a la notion de comorbidite et concept de dual diagnosis. In: Addictions et comorbidites. Ed Dunod Paris, 2014, p.3-10.
2. Glass GS, Bowers MB. Chronic psychosis associated with long term psychotomimetic drug abuse. Arch Gen Psychiatry 1970;23:97-103.
3. Luquiens A Epidemiologic et impact medico economique des pathologies duelles. In: Addictions et comorbidites. Ed Donod Paris, 2014, p.11-18.
4. DiFlorio A, Craddock N, Van den Bree M. Alcohol misuse in bipolar disorder. A systematic review and metanalysis of comorbidity rate. European Psychiatry 2014;29:117-24.
5. Hasin DS, Stinson FS, Ogburn E, et al Prevalence correlates, disability and comorbidity of DSMIV alcohol abuse in US results from the National Epidemiologic Survey on Alcohol and related conditions. Arch Gen Psychiatry 2007;64:830-42.
6. Shield KD, Rylett M, Gmel G, et al. Global alcohol exposure estimates by country, territory and region for 2005 A contribution to the comparative risk assessment for the 2010 Global Burden ofdisease Study. Addiction 2013;108:912-22
7. Nutt DJ, King LA, Phillips LD. Drug harms in the UK: A multicri-teria decision analysis. The Lancet 2010;376:1558-65.
8. Boschloo L, Vogelzangs N, Brink W, et al. Predictor of two years recurrence and persistence of alcohol dependence. Addiction 2012;107:1639-40.
9. Nehlin C, Gronbladh L, Fredrikson, et al. Alcohol and drug use, smoking, and gambling among psychiatric outpatients: A 1-year prevalence. Substance Abuse 2013;34:162-8.
10. Carmiol N, Peralta JM, Almasy, et al Shared genetic factors influence risk for bipolar disorder and alcohol use disorders. European Psychiatry 2014;29:282-7.
11. Wolistzky-Taylor K, Bobova L, Zinbarg RE, et al. Longitudinal investigation of the impact of anxiety and mood disorders in adolescence on subsequent substance use disorder onset and vice-versa. Addictive Behaviors 2012;38:982-5.
12. Hunt SA, Baker AL, Michie PT, et al. Neurocogntive profile of people with comorbid depression and alcohol use: Implications for psychological interventions Addictive Behaviors 2009;34:878-86.
13. Conrod PL, O'Leary-Barett M, Newton N, et al. Effectiveness of a selective, personality-targeted prevention program for adolescent alcohol use and misuse: A cluster randomized controlled trial JAMA Psychiatry 2013;70:334-42.
14. Icik R, Bellivier F. Alcool. In: Addictions et comorbidites. Ed Dunod Paris, 2014, p.171-191.
15. Kraus A. L'ivresse maniaque. In: Les ivresses. Ed L'Esprit du temps Paris, 1994, p.112-119.
16. Kimura Bin. Pathologie de I'lmmediatete. In: Ecrits de Psy-chopathologie Phenomenologique. Ed PUF Psychiatrie Ouverte 1992, p. 129-162.
17. Elbogen EB, Johnson SC. The intricate link between violence and mental disorder: results from the national epidemiologic survey on alcohol and related conditions. Ach Gen Psychiatry 2009;66:152-61.
18. Salom CL, Betts KS, Williams GM, et al. Do young people with comorbid mental and alcohol disorders experience worse behavioural problems? Psychiatry Res. 2014 Oct 30;219:372-9
19. Skule C, Dallavara Lending H, Ulleberg P, et al. Alcohol use is not directly related to the perceived control of depressive symptoms in patients with depressive symptoms. Frontiers in Psychiatry 2014;5:31.
20. Lovallo WR, Enoch MA, Yechiam E, et al Differential impact of serotonin transporter activity on temperament and behavior in persons with a family history of alcoholism in the Oklahoma family health patterns project. Alcohol Clin Exper Res 2014;38:1575-81.
21. Sjoholm LK, Kovanen L, SaarikskiST, et al. Clock is suggested to associate with comorbid alcohol use and depressive disorders. Journal ofCircadian Rhythms 2010;8:1-9.
22. Gonzales R, Bernardo C, Cruz D, et al. The relationships between clinical characteristics, alcohol and psychotropic exposure, and circadian gene expression in human post-mortem samples of affective disorder and control subjects. Psychiatry Research 2014;218:359-362.
23. DematteisM, MallaretM. Les therapies medicamenteuses. In: Addictions et comorbidites. Ed Donod Paris, 2014, p.331-353.
24. Hobbs JD, Kushner MG, Lee SS, et al. Meta-analysis of supplemental treatment for depressive and anxiety disorders in patients being treated for alcohol dependence. Am J Addict 2011;20:319-29.
25. Mann K, Bladstrom A, Torup L, et al. Extending the treatment options in alcohol dependence: A randomized controlled study ofas need nalmefene. Biol Psychiatry 2013;73:706-13.
26. Kenna GA, Zywiak WH, Swift RM, et al. Ondansetron reduce naturalistic drinking in non-treatment seeking achohol dependent individuals with the LL5'-HTTPLPR genotype: A laboratory study. Alcohol Clin Exp Res 2014;38:1567-74.
27. Brown ES, Davilla D, Nakamura A, et al. A randomized double blind placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase and alcohol dependence. Alcohol Clin Exp Res 2014;38:2113-8.
28. Hunt GE, Siegfried N, Morley K, et al. Psychosocial interventions for people with both severe mental illness and substance misuse. Schizophr Bull 2014;40:18-20.
29. Riper H, Andersson G, Hunter SB, et al. Treatment of comorbid alcohol use disorders and depression with cognitive-behavioural therapy and motivational interviewing: A meta-analysis Addiction 2014;109:394-406.
30. Hall W, Degenhardt L, Teeson M. Understanding comorbidity between substance use, anxiety and affective disorders: broadening the research base. Addictive Behaviors 2009;34:526-530.